Literature DB >> 34269619

Afferent Visual Manifestations of Traumatic Brain Injury.

Noor Haziq Saliman1,2,3, Antonio Belli1,2, Richard J Blanch1,2,3,4.   

Abstract

Traumatic brain injury (TBI) causes structural and functional damage to the central nervous system including the visual pathway. Defects in the afferent visual pathways affect visual function and in severe cases cause complete visual loss. Visual dysfunction is detectable by structural and functional ophthalmic examinations that are routine in the eye clinic, including examination of the pupillary light reflex and optical coherence tomography (OCT). Assessment of pupillary light reflex is a non-invasive assessment combining afferent and efferent visual function. While a assessment using a flashlight is relatively insensitive, automated pupillometry has 95% specificity and 78.1% sensitivity in detecting TBI-related visual and cerebral dysfunction with an area under the curve of 0.69-0.78. OCT may also serve as a noninvasive biomarker of TBI severity, demonstrating changes in the retinal ganglion cell layer and nerve fiber layer throughout the range of TBI severity even in the absence of visual symptoms. This review discusses the impact of TBI on visual structure and function.

Entities:  

Keywords:  ganglion cell layer; optical coherent tomography; retinal nerve fiber layer; traumatic brain injury; traumatic optic neuropathy; visual function

Mesh:

Substances:

Year:  2021        PMID: 34269619     DOI: 10.1089/neu.2021.0182

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  2 in total

Review 1.  Mild-to-Moderate Traumatic Brain Injury: A Review with Focus on the Visual System.

Authors:  Steven H Rauchman; Jacqueline Albert; Aaron Pinkhasov; Allison B Reiss
Journal:  Neurol Int       Date:  2022-05-30

2.  A differential of the left eye and right eye neurological pupil index is associated with discharge modified Rankin scores in neurologically injured patients.

Authors:  Claudio M Privitera; Sanjay V Neerukonda; Venkatesh Aiyagari; Shoji Yokobori; Ava M Puccio; Nathan J Schneider; Sonja E Stutzman; DaiWai M Olson
Journal:  BMC Neurol       Date:  2022-07-22       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.